Aeolus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	2007 - 2011
Period Ending	Jun '25 Jun 4, 2025	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012	2007 - 2011
Market Capitalization	0	29	33	34	38	23	Upgrade
Market Cap Growth	-52.03%	-11.64%	-2.77%	-10.71%	62.31%	-8.61%	Upgrade
Enterprise Value	-	25	32	32	35	23	Upgrade
Last Close Price	0.00	0.19	0.24	0.25	0.28	0.37	Upgrade
PE Ratio	-	-	-	-	-	27.12	Upgrade
PS Ratio	0.02	13.92	10.51	3.49	9.59	3.18	Upgrade
PB Ratio	0.07	9.04	-38.70	21.22	53.44	-1.14	Upgrade
P/TBV Ratio	0.07	9.04	-	21.29	53.82	-	Upgrade
P/FCF Ratio	-	-	-	104.14	-	-	Upgrade
P/OCF Ratio	-	-	-	104.14	-	-	Upgrade
EV/Sales Ratio	-	12.11	10.38	3.36	8.90	3.16	Upgrade
EV/FCF Ratio	-	-	-	100.22	-	-	Upgrade
Debt / Equity Ratio	-	-	-1.19	-	-	-	Upgrade
Asset Turnover	0.27	0.70	1.16	3.47	2.44	4.11	Upgrade
Quick Ratio	1.22	4.02	0.64	1.54	0.98	0.47	Upgrade
Current Ratio	1.30	4.25	0.67	1.78	1.53	0.54	Upgrade
Return on Equity (ROE)	-186.43%	-302.81%	-710.27%	-6.99%	-	-	Upgrade
Return on Assets (ROA)	-90.30%	-68.83%	-61.27%	-1.80%	-104.67%	-83.58%	Upgrade
Return on Capital (ROIC)	-116.52%	-122.05%	-188.43%	-4.37%	-	-	Upgrade
Earnings Yield	-26918.27%	-12.31%	-8.04%	-0.24%	-8.52%	7.32%	Upgrade
FCF Yield	-	-10.76%	-7.47%	0.96%	-7.88%	-3.79%	Upgrade
Buyback Yield / Dilution	-5.16%	-9.41%	-0.90%	-26.38%	-49.99%	17.26%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.